Recent developments in genomewide association scans: a workshop summary and review.

PubWeight™: 3.76‹?› | Rank: Top 1%

🔗 View Article (PMC 1226200)

Published in Am J Hum Genet on August 01, 2005

Authors

Duncan C Thomas1, Robert W Haile, David Duggan

Author Affiliations

1: Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90089-9011, USA. dthomas@usc.edu

Articles citing this

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

Genome-wide associations of gene expression variation in humans. PLoS Genet (2005) 17.27

Using linkage genome scans to improve power of association in genome scans. Am J Hum Genet (2006) 5.67

A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet (2007) 4.21

Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet (2007) 3.92

Heritability of alternative splicing in the human genome. Genome Res (2007) 2.76

Genotyping pooled DNA using 100K SNP microarrays: a step towards genomewide association scans. Nucleic Acids Res (2006) 2.33

Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLoS Comput Biol (2008) 2.32

Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer (2009) 2.13

Genome wide association studies for milk production traits in Chinese Holstein population. PLoS One (2010) 2.13

Genome-wide quantitative trait locus association scan of general cognitive ability using pooled DNA and 500K single nucleotide polymorphism microarrays. Genes Brain Behav (2008) 2.08

Evaluating statistical significance in two-stage genomewide association studies. Am J Hum Genet (2006) 1.95

Genome-wide association studies and beyond. Annu Rev Public Health (2010) 1.73

A flexible Bayesian framework for modeling haplotype association with disease, allowing for dominance effects of the underlying causative variants. Am J Hum Genet (2006) 1.70

Bayesian graphical models for genomewide association studies. Am J Hum Genet (2006) 1.66

Fine mapping versus replication in whole-genome association studies. Am J Hum Genet (2007) 1.64

Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn Neuropsychiatry (2009) 1.60

Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC Genet (2008) 1.53

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood (2013) 1.52

From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev (2008) 1.35

A note on permutation tests in multistage association scans. Am J Hum Genet (2006) 1.28

Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer (2011) 1.17

Genes, cognition, and communication: insights from neurodevelopmental disorders. Ann N Y Acad Sci (2009) 1.16

Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing. Pharmacogenomics (2007) 1.12

The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment. Eur J Hum Genet (2008) 1.09

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Br J Cancer (2009) 1.08

Shrinkage estimation for robust and efficient screening of single-SNP association from case-control genome-wide association studies. Genet Epidemiol (2009) 1.00

Goldsurfer2 (Gs2): a comprehensive tool for the analysis and visualization of genome wide association studies. BMC Bioinformatics (2008) 1.00

Evaluation of genome-wide association study results through development of ontology fingerprints. Bioinformatics (2009) 0.99

Bayesian semiparametric multiple shrinkage. Biometrics (2009) 0.98

Molecular genetic studies of gene identification for sarcopenia. Hum Genet (2011) 0.97

A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. BMC Genet (2007) 0.95

Physical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6. PLoS One (2011) 0.88

Microarrays. Dev Sci (2007) 0.87

The nature of nurture: a genomewide association scan for family chaos. Behav Genet (2008) 0.87

SUP: an extension to SLINK to allow a larger number of marker loci to be simulated in pedigrees conditional on trait values. BMC Genet (2006) 0.86

Genetics and genomics of endometriosis. Clin Obstet Gynecol (2010) 0.86

Detecting genome wide haplotype sharing using SNP or microsatellite haplotype data. Hum Genet (2005) 0.86

Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. PLoS One (2009) 0.86

Kernel canonical correlation analysis for assessing gene-gene interactions and application to ovarian cancer. Eur J Hum Genet (2013) 0.85

A modified forward multiple regression in high-density genome-wide association studies for complex traits. Genet Epidemiol (2009) 0.85

Analyzes of genome-wide association follow-up study for calving traits in dairy cattle. BMC Genet (2012) 0.83

Practical aspects of genome-wide association interaction analysis. Hum Genet (2014) 0.79

Correction for population stratification in random forest analysis. Int J Epidemiol (2012) 0.79

Joint modeling of linkage and association using affected sib-pair data. BMC Proc (2007) 0.78

Meta analysis of whole-genome linkage scans with data uncertainty: an application to Parkinson's disease. BMC Genet (2007) 0.77

A short history of the genome-wide association study: where we were and where we are going. Genomics Inform (2012) 0.77

Assessment of systematic effects of methodological characteristics on candidate genetic associations. Hum Genet (2012) 0.77

Association of Agronomic Traits with SNP Markers in Durum Wheat (Triticum turgidum L. durum (Desf.)). PLoS One (2015) 0.76

Significant overlap between human genome-wide association-study nominated breast cancer risk alleles and rat mammary cancer susceptibility loci. Breast Cancer Res (2014) 0.76

Semi-supervised spectral clustering with application to detect population stratification. Front Genet (2013) 0.75

Applying genome-wide gene-based expression quantitative trait locus mapping to study population ancestry and pharmacogenetics. BMC Genomics (2014) 0.75

Accurate phenotyping: Reconciling approaches through Bayesian model averaging. PLoS One (2017) 0.75

Articles cited by this

(truncated to the top 100)

Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64

The future of genetic studies of complex human diseases. Science (1996) 64.76

SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res (2003) 52.26

Detection of large-scale variation in the human genome. Nat Genet (2004) 49.18

The ENCODE (ENCyclopedia Of DNA Elements) Project. Science (2004) 38.24

Large-scale copy number polymorphism in the human genome. Science (2004) 34.64

Genome-wide association studies for common diseases and complex traits. Nat Rev Genet (2005) 33.96

Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10

Genetic analysis of genome-wide variation in human gene expression. Nature (2004) 27.28

Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet (1999) 25.93

Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet (1998) 22.90

Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet (2001) 22.46

Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet (2003) 21.52

Whole-genome patterns of common DNA variation in three human populations. Science (2005) 21.22

Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet (1990) 19.91

Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst (2004) 19.00

Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95

Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79

Ultraconserved elements in the human genome. Science (2004) 17.14

Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science (2005) 16.82

Association mapping in structured populations. Am J Hum Genet (2000) 16.79

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet (2003) 16.51

Assessing the impact of population stratification on genetic association studies. Nat Genet (2004) 16.28

On the allelic spectrum of human disease. Trends Genet (2001) 16.26

Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet (2005) 14.88

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet (2004) 14.76

Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet (2005) 14.30

Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet (2003) 13.60

Methods for high-density admixture mapping of disease genes. Am J Hum Genet (2004) 12.02

Empirical bayes methods and false discovery rates for microarrays. Genet Epidemiol (2002) 10.56

Population stratification and spurious allelic association. Lancet (2003) 10.53

Variations on a theme: cataloging human DNA sequence variation. Science (1997) 10.49

The allelic architecture of human disease genes: common disease-common variant...or not? Hum Mol Genet (2002) 10.08

Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods (2004) 9.52

Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10

Association study designs for complex diseases. Nat Rev Genet (2001) 8.91

Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered (2002) 8.64

A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet (2005) 7.64

The health of Hispanics in the southwestern United States: an epidemiologic paradox. Public Health Rep (1986) 7.34

Mapping complex disease loci in whole-genome association studies. Nature (2004) 7.31

Population history and natural selection shape patterns of genetic variation in 132 genes. PLoS Biol (2004) 7.11

Genomic control, a new approach to genetic-based association studies. Theor Popul Biol (2001) 6.90

Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet (2002) 6.46

Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann Hum Genet (2000) 6.13

Optimal two-stage genotyping in population-based association studies. Genet Epidemiol (2003) 6.01

Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev (2002) 6.00

Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet (2001) 5.99

Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies. Nat Genet (2004) 5.78

DNA Pooling: a tool for large-scale association studies. Nat Rev Genet (2002) 5.66

Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res (2004) 5.59

The future of association studies: gene-based analysis and replication. Am J Hum Genet (2004) 5.44

Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet (2003) 5.30

Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol (2003) 4.94

Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet (2002) 4.76

Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet (2000) 4.74

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res (2004) 4.54

Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet (2004) 4.51

Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst (2000) 4.51

Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered (2003) 4.34

Linkage disequilibrium: what history has to tell us. Trends Genet (2002) 4.33

Estimation of the inbreeding coefficient through use of genomic data. Am J Hum Genet (2003) 4.01

Pattern of sequence variation across 213 environmental response genes. Genome Res (2004) 3.93

Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. Am J Phys Anthropol (2001) 3.76

Two-stage designs for gene-disease association studies. Biometrics (2002) 3.67

Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci U S A (2004) 3.62

Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol (1999) 3.31

Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med (1995) 3.31

On the identification of disease mutations by the analysis of haplotype similarity and goodness of fit. Am J Hum Genet (2003) 3.16

Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev (2002) 2.99

Admixture studies in Latin America: from the 20th to the 21st century. Hum Biol (2000) 2.96

False discovery rate in linkage and association genome screens for complex disorders. Genetics (2003) 2.89

Association testing by DNA pooling: an effective initial screen. Proc Natl Acad Sci U S A (2002) 2.79

The impact of SNP density on fine-scale patterns of linkage disequilibrium. Hum Mol Genet (2004) 2.78

A transmission/disequilibrium test that allows for genotyping errors in the analysis of single-nucleotide polymorphism data. Am J Hum Genet (2001) 2.68

Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test. Am J Hum Genet (2003) 2.51

Identification of the sources of error in allele frequency estimations from pooled DNA indicates an optimal experimental design. Ann Hum Genet (2002) 2.51

The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer (2004) 2.47

Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics (2004) 2.21

Limits of resolution of genetic linkage studies: implications for the positional cloning of human disease genes. Am J Hum Genet (1994) 2.20

Two-stage designs for gene-disease association studies with sample size constraints. Biometrics (2004) 2.08

Cost-effective analysis of candidate genes using htSNPs: a staged approach. Genes Immun (2004) 2.07

Genetic differentiation in South Amerindians is related to environmental and cultural diversity: evidence from the Y chromosome. Am J Hum Genet (2001) 2.00

Novel association approach for determining the genetic predisposition to schizophrenia: case-control resource and testing of a candidate gene. Am J Med Genet (1993) 1.95

Cancer statistics for Hispanics, 2003. CA Cancer J Clin (2003) 1.88

Y-chromosome evidence for differing ancient demographic histories in the Americas. Am J Hum Genet (2003) 1.84

"Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. Am J Hum Genet (2003) 1.82

Linkage disequilibrium patterns and tagSNP transferability among European populations. Am J Hum Genet (2005) 1.72

Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet (2003) 1.71

Two-Stage sampling designs for gene association studies. Genet Epidemiol (2004) 1.70

Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature (2004) 1.68

Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet (2005) 1.67

PARSESNP: A tool for the analysis of nucleotide polymorphisms. Nucleic Acids Res (2003) 1.63

Increasing power for tests of genetic association in the presence of phenotype and/or genotype error by use of double-sampling. Stat Appl Genet Mol Biol (2004) 1.61

Finding haplotype tagging SNPs by use of principal components analysis. Am J Hum Genet (2004) 1.61

Sequence first. Ask questions later. Cell (2002) 1.55

How many SNPs does a genome-wide haplotype map require? Pharmacogenomics (2002) 1.54

On the statistical analysis of allelic-loss data. Stat Med (1998) 1.33

An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res (2004) 1.30

Allowing for genotyping error in analysis of unmatched case-control studies. Ann Hum Genet (2003) 1.21

Articles by these authors

Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet (2008) 20.38

Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34

A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93

Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst (2007) 4.24

Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet (2011) 3.73

Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst (2003) 3.44

Variation of breast cancer risk among BRCA1/2 carriers. JAMA (2008) 3.30

Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14

Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst (2013) 3.06

A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes (2007) 2.67

Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst (2009) 2.64

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57

Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol (2010) 2.50

Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet (2011) 2.47

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst (2012) 2.44

Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology (2007) 2.39

Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38

Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut (2010) 2.30

Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res (2009) 2.27

Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol (2012) 2.22

Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15

Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev (2008) 2.12

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res (2004) 2.03

Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res (2007) 2.02

Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst (2010) 1.99

Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet (2009) 1.90

Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev (2009) 1.88

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol (2010) 1.85

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol (2004) 1.83

A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82

Two independent prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev (2009) 1.78

Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst (2007) 1.73

Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev (2009) 1.72

Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst (2004) 1.67

Evaluation of the metabochip genotyping array in African Americans and implications for fine mapping of GWAS-identified loci: the PAGE study. PLoS One (2012) 1.65

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A (2010) 1.59

Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58

Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys (2008) 1.58

Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet (2013) 1.57

Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat (2013) 1.55

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. Prostate (2008) 1.53

Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52

A novel prostate cancer susceptibility locus at 19q13. Cancer Res (2009) 1.49

Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev (2002) 1.48

Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat (2011) 1.47

Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum Genet (2012) 1.47

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat (2010) 1.40

The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev (2009) 1.35

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate (2009) 1.33

Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat (2003) 1.33

Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res (2010) 1.32

Recombination and its impact on the genome of the haplodiploid parasitoid wasp Nasonia. PLoS One (2010) 1.31

Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res (2009) 1.29

Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet (2013) 1.27

Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn (2011) 1.27

Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Prostate (2008) 1.24

Dissecting effects of complex mixtures: who's afraid of informative priors? Epidemiology (2007) 1.21

Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. J Natl Cancer Inst (2007) 1.18

Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res (2010) 1.17

Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control study. Carcinogenesis (2004) 1.16

Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila) (2010) 1.15

A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study. Prostate (2006) 1.15

A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Hum Mutat (2012) 1.14

cis-Expression QTL analysis of established colorectal cancer risk variants in colon tumors and adjacent normal tissue. PLoS One (2012) 1.14

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol (2012) 1.13

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat (2010) 1.11

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. J Natl Cancer Inst (2006) 1.11

Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer (2011) 1.10

Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev (2002) 1.10

Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients. Prostate (2008) 1.10

Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis (2008) 1.10

Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer Res (2009) 1.09

Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.08

Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev (2010) 1.07

Methodological Issues in Multistage Genome-wide Association Studies. Stat Sci (2009) 1.06

Neuregulin induces the expression of transcription factors and myosin heavy chains typical of muscle spindles in cultured human muscle. Proc Natl Acad Sci U S A (2004) 1.06

Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev (2010) 1.06

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst (2009) 1.05

Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev (2008) 1.05

Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res (2010) 1.05

Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res (2010) 1.04

Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling. Genet Epidemiol (2011) 1.04

Vancomycin-induced thrombocytopenia: a case proven with rechallenge. Pharmacotherapy (2003) 1.04

Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn (2010) 1.04

Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr Cancer (2012) 1.03

A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol Biomarkers Prev (2014) 1.03

Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol Biomarkers Prev (2010) 1.03

Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol (2013) 1.03

Accuracy of colorectal polyp self-reports: findings from the colon cancer family registry. Cancer Epidemiol Biomarkers Prev (2007) 1.03

XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2006) 1.02

Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res (2008) 1.00

Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol (2009) 1.00

Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women. Am J Gastroenterol (2012) 0.99

Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiol Biomarkers Prev (2007) 0.99